tirzepatide non diabetics GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Non diabetic taking Tirzepatide (Zepbound)for
Description
in its 12th acquisition of '26, Lilly enters the psychedelics aisle w/$2.8B upfront move for AtaiBeckley GLP-1 giant, once known for its depression med Prozac, gets 3 clinical-stage brain health drug candidates follows J&J, AbbVie, Otsuka in psychedelics
A head-to-head trial finds Zepbound is superior to Wegovy for weight loss
Novo Nordisks deal with Emcure for semaglutide will launch Poviztra as a second obesity brand in India, improving access to weight loss treatments following a Lilly-Cipla deal for tirzepatide and seems a clever counter to Indian majors planning to launch generic semaglutide next year
Type 2 Diabetes & Obesity 2
Beligas Semaglutide + Beligas Test E: Combination for weight control and metabolism boost with testosterone enanthate for muscle growth and strength.
For the best results, consume at least 3 liters of water each day
